Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | TACR2 | P21452 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6685567 | 0.94 | CNR1 (0.52) | CNR1CNR2CYP1A2PTPN1NPC1 | |
| SCHEMBL29946510 | 0.88 | PTGS2 (0.55) | PTPN1NPC1RAB9AESR1CYP3A4 | |
| SCHEMBL2048075 | 0.88 | PTGS2 (0.55) | PTPN1NPC1RAB9AESR1CYP3A4 | |
| SCHEMBL31593166 | 0.87 | CNR1 (0.54) | CNR1CNR2CYP1A2NPC1MAPT | |
| SCHEMBL7193556 | 0.87 | CNR1 (0.54) | CNR1CNR2CYP1A2NPC1MAPT | |
| SCHEMBL4065606 | 0.86 | PTGS2 (0.63) | PTPN1MAPTESR1CYP3A4ADRA2A | |
| SCHEMBL9700041 | 0.85 | PTGS2 (0.67) | MAPTESR1CYP3A4ADRA2AADORA3 | |
| SCHEMBL2049841 | 0.85 | PTGS2 (0.67) | MAPTESR1CYP3A4ADRA2AADORA3 | |
| SCHEMBL2050474 | 0.85 | PTGS2 (0.67) | MAPTESR1CYP3A4ADRA2AADORA3 | |
| SCHEMBL3153673 | 0.85 | ESR1 (0.62) | CYP1A2ESR1CYP3A4ESR2CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115448862-B | Binaphthyl series liquid crystal monomer compound and preparation method and application thereof | 中节能万润股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-115448862-A | Binaphthyl series liquid crystal monomer compound and preparation method and application thereof | 中节能万润股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| WO-2022186312-A1 | PROTECTION FILM FORMATION COMPOSITION | 日産化学株式会社 | 2022-09-09 | — | — | WO | disclosed |
| EP-2557103-B1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DAINIPPON INK & CHEMICALS (JP) | 2014-11-26 | — | — | EP | disclosed |
| US-8519065-B2 | Epoxy compound, curable composition, and cured product thereof | DIC CORPORATION (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20130190497-A1 | FLUORESCENT SUBSTRATES FOR MONOAMINE TRANSPORTERS AS OPTICAL FALSE NEUROTRANSMITTERS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2013-07-25 | — | — | US | disclosed |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| EP-2557103-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | DIC Corporation (JP) | 2013-02-13 | — | — | EP | disclosed |
| US-8344080-B2 | Catalyst for olefin polymerization and method of preparation thereof | WANG LICAI (CN) | 2013-01-01 | — | — | US | disclosed |
| US-8337941-B2 | Fluorescent substrates for monoamine transporters as optical false neurotransmitters | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2012-12-25 | — | — | US | disclosed |
| EP-1452514-B1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK & CHEMICALS (JP) | 2010-03-31 | — | — | EP | disclosed |
| EP-1273562-B1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK & CHEMICALS (JP) | 2009-07-22 | — | — | EP | disclosed |
| US-20080161513-A1 | Catalyst for Olefin Polymerization and Preparation Thereof and Polymerization Process | YINGKOU XIANGYANG CATALYST CO., LTD. (CN) | 2008-07-03 | — | — | US | disclosed |
| US-7145047-B2 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-12-05 | — | — | US | disclosed |
| EP-0952135-B1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK & CHEMICALS (JP) | 2005-01-05 | — | — | EP | disclosed |
| EP-1452514-A1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-09-01 | — | — | EP | disclosed |
| US-20030136944-A1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-07-24 | — | — | US | disclosed |
| EP-1273562-A1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-01-08 | — | — | EP | disclosed |
| US-6468607-B1 | MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-10-22 | — | — | US | disclosed |
| EP-0952135-A1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030136944-A1 | Naphthalene derivative and liquid crystal composition comprising the same | NLK, NOTCH1, NOTCH4 | CNR1 1891/4885CNR2 1584/4885CYP1A2 959/4885 |
| US-20130190497-A1 | FLUORESCENT SUBSTRATES FOR MONOAMINE TRANSPORTERS AS OPTICAL FALSE NEUROTRANSMITTERS | SLC18A2, SLC6A2, SLC18A3 | CNR1 294/4885CNR2 316/4885CYP1A2 1053/4885 |
| US-20130144030-A1 | EPOXY COMPOUND, CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | HEATR1, EEF1A1, EPN1 | CNR1 398/4885CNR2 965/4885CYP1A2 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.